
MyungMoon Bio to sell ACell's wound matrix products in South Korea
Executive Summary
ACell Inc. granted MyungMoon Bio Co. Ltd. exclusive rights to market and distribute its wound management matrix products in South Korea.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice